Clinuvel Pharmaceutical Forecast, price target & analysts
Clinuvel Pharmaceutical Target price 2026 - Analyst rating & recommendation
Clinuvel Pharmaceutical Classifications & Recommendation
Clinuvel Pharmaceutical Price Target
| Target Price | A$14.72 |
| Price | A$7.33 |
| Potential | |
| Number of Estimates | 8 |
| 8 Analysts have issued a price target Clinuvel Pharmaceutical 2027 . The average Clinuvel Pharmaceutical target price is A$14.72. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 11 analysts: 7 Analysts recommend Clinuvel Pharmaceutical to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Clinuvel Pharmaceutical stock has an average upside potential 2027 of . Most analysts recommend the Clinuvel Pharmaceutical stock at Purchase. |
Sales and Margin forecast 2027, 2028 & 2029
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Million A$ | ??? | ??? |
| ??? | ??? | |
| Net Margin | ??? | ??? |
| ??? | ??? |
9 Analysts have issued a sales forecast Clinuvel Pharmaceutical 2027 . The average Clinuvel Pharmaceutical sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
9 Clinuvel Pharmaceutical Analysts have issued a net profit forecast 2027. The average Clinuvel Pharmaceutical net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share A$ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
9 Analysts have issued a Clinuvel Pharmaceutical forecast for earnings per share. The average Clinuvel Pharmaceutical EPS is
. This is than earnings per share in the financial year 2026. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Clinuvel Pharmaceutical...
Current Clinuvel Pharmaceutical Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| Analyst Rating | Date |
|---|---|
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
